Patents by Inventor David Keane

David Keane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250025055
    Abstract: A Percutaneous Coronary Intervention (PCI) guidewire and method of use includes at least two pairs of small surface area, closely spaced electrodes spaced axially along the length of the guidewire to allow one electrode pair to be positioned on each side of a coronary stenosis. The electrodes can sense electrical signals from the myocardium immediately adjacent to the electrodes, enabling the guidewire to record and analyze an Intra-Coronary Electrogram (ICEG) and heart pacing, and, therefore, facilitate more accurately diagnosis of an individual patient's stenosis and provide a more patient specific diagnosis of clinical need.
    Type: Application
    Filed: May 29, 2024
    Publication date: January 23, 2025
    Inventor: David Keane
  • Patent number: 12204571
    Abstract: Disclosed is a content publisher recommender system comprising: a server; a content database, configured within the server, within which are stored one or more channels associated with an end user, wherein the one or more channels stores at least one end user identification and a user historical database including a time log of the end user's activity, a log of search phrases used by the end user, a record of results identified on the search phrases; a ranking of the record of results, a record of which results the end user interacts with and a record of the format of the first clicked results from an end user wherein the search phrases are analysed using natural language processing to reduce the terms of the search phrases to their root form, the terms of the phrase are broken down into their part of speech and all keywords identified during natural language processing have stop words removed; and wherein considerations of the stored data and the analysis provides a ranking for searching to provide recommend
    Type: Grant
    Filed: November 11, 2021
    Date of Patent: January 21, 2025
    Assignee: BIGTINCAN MOBILE PTY LTD
    Inventors: Thaison Tran, George Ye, David Keane
  • Patent number: 12023131
    Abstract: A Percutaneous Coronary Intervention (PCI) guidewire and method of use includes at least two pairs of small surface area, closely spaced electrodes spaced axially along the length of the guidewire to allow one electrode pair to be positioned on each side of a coronary stenosis. The electrodes can sense electrical signals from the myocardium immediately adjacent to the electrodes, enabling the guidewire to record and analyze an Intra-Coronary Electrogram (ICEG) and heart pacing, and, therefore, facilitate more accurately diagnosis of an individual patient's stenosis and provide a more patient specific diagnosis of clinical need.
    Type: Grant
    Filed: November 6, 2020
    Date of Patent: July 2, 2024
    Assignee: CARDIOWIRE LIMITED
    Inventor: David Keane
  • Patent number: 12016660
    Abstract: A Percutaneous Coronary Intervention (PCI) guidewire and method of use includes at least two pairs of small surface area, closely spaced electrodes spaced axially along the length of the guidewire to allow one electrode pair to be positioned on each side of a coronary stenosis. The electrodes can sense electrical signals from the myocardium immediately adjacent to the electrodes, enabling the guidewire to record and analyze an Intra-Coronary Electrogram (ICEG) and heart pacing, and, therefore, facilitate more accurately diagnosis of an individual patient's stenosis and provide a more patient specific diagnosis of clinical need.
    Type: Grant
    Filed: February 9, 2023
    Date of Patent: June 25, 2024
    Assignee: CARDIOWIRE LIMITED
    Inventor: David Keane
  • Publication number: 20240108448
    Abstract: A method and prosthesis is provided for percutaneous repair of an anatomical defect, such as an iguinal hernia. The method involves percutaneously accessing the inguinal canal of a patient. Following hernia reduction, if required, the hernia defect may be accessed and repaired percutaneously from within the inguinal canal. An implantable prosthesis may be percutaneously delivered into the inguinal canal. The prosthesis may be advanced along the inguinal canal from the percutaneous entry location to the defect site, where it may be developed over and/or within the defect. A biocompatible foam material may be percutaneously delivered into the inguinal canal to reduce and/or repair the hernia defect. The foam may fill and solidify in the canal to prevent abdominal viscera from reentering the canal. Ablative therapy may be performed within the inguinal canal to cause a fibrotic response resulting in scar tissue formation and/or tissue shrinkage that narrows the canal.
    Type: Application
    Filed: October 2, 2023
    Publication date: April 4, 2024
    Applicant: PerQHern Limited
    Inventor: David Keane
  • Publication number: 20230320594
    Abstract: A Percutaneous Coronary Intervention (PCI) guidewire and method of use includes at least two pairs of small surface area, closely spaced electrodes spaced axially along the length of the guidewire to allow one electrode pair to be positioned on each side of a coronary stenosis. The electrodes can sense electrical signals from the myocardium immediately adjacent to the electrodes, enabling the guidewire to record and analyze an Intra-Coronary Electrogram (ICEG) and heart pacing, and, therefore, facilitate more accurately diagnosis of an individual patient’s stenosis and provide a more patient specific diagnosis of clinical need.
    Type: Application
    Filed: February 9, 2023
    Publication date: October 12, 2023
    Inventor: David Keane
  • Patent number: 11771542
    Abstract: A method and prosthesis is provided for percutaneous repair of an anatomical defect, such as an inguinal hernia. The method involves percutaneously accessing the inguinal canal of a patient. Following hernia reduction, if required, the hernia defect may be accessed and repaired percutaneously from within the inguinal canal. An implantable prosthesis may be percutaneously delivered into the inguinal canal. The prosthesis may be advanced along the inguinal canal from the percutaneous entry location to the defect site, where it may be deployed over and/or within the defect. A biocompatible foam material may be percutaneously delivered into the inguinal canal to reduce and/or repair the hernia defect. The foam may fill and solidify in the canal to prevent abdominal viscera from reentering the canal. Ablative therapy may be performed within the inguinal canal to cause a fibrotic response resulting in scar tissue formation and/or tissue shrinkage that narrows the canal.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: October 3, 2023
    Assignee: PerQHern Limited
    Inventor: David Keane
  • Patent number: 11160655
    Abstract: An implantable intracardiac device to prevent systolic anterior motion of the anterior mitral valve leaflet into the left ventricular outflow tract is described. The device comprises a blocking member configured for implantation within the left ventricle of the heart and in-situ blocking of systolic anterior motion of the mitral valve into the left ventricular outflow tract when anchored into the left ventricle of the heart. The device may be configured for radial expansion from a contracted orientation suitable for transluminal delivery to the left ventricle of the heart within a suitable delivery vehicle and an expanded orientation suitable for deployment within the left ventricle of the heart. The device comprises anchors configured for anchoring the device in-situ within the left ventricle to a wall of the left ventricle.
    Type: Grant
    Filed: June 18, 2018
    Date of Patent: November 2, 2021
    Assignee: PARADOX MEDICAL LIMITED
    Inventor: David Keane
  • Publication number: 20210161396
    Abstract: A Percutaneous Coronary Intervention (PCI) guidewire and method of use includes at least two pairs of small surface area, closely spaced electrodes spaced axially along the length of the guidewire to allow one electrode pair to be positioned on each side of a coronary stenosis. The electrodes can sense electrical signals from the myocardium immediately adjacent to the electrodes, enabling the guidewire to record and analyze an Intra-Coronary Electrogram (ICEG) and heart pacing, and, therefore, facilitate more accurately diagnosis of an individual patient's stenosis and provide a more patient specific diagnosis of clinical need.
    Type: Application
    Filed: November 6, 2020
    Publication date: June 3, 2021
    Inventor: David Keane
  • Publication number: 20210106416
    Abstract: A method and prosthesis is provided for percutaneous repair of an anatomical defect, such as an inguinal hernia. The method involves percutaneously accessing the inguinal canal of a patient. Following hernia reduction, if required, the hernia defect may be accessed and repaired percutaneously from within the inguinal canal. An implantable prosthesis may be percutaneously delivered into the inguinal canal. The prosthesis may be advanced along the inguinal canal from the percutaneous entry location to the defect site, where it may be deployed over and/or within the defect. A biocompatible foam material may be percutaneously delivered into the inguinal canal to reduce and/or repair the hernia defect. The foam may fill and solidify in the canal to prevent abdominal viscera from reentering the canal. Ablative therapy may be performed within the inguinal canal to cause a fibrotic response resulting in scar tissue formation and/or tissue shrinkage that narrows the canal.
    Type: Application
    Filed: April 3, 2020
    Publication date: April 15, 2021
    Inventor: David Keane
  • Patent number: 10617506
    Abstract: A method and prosthesis is provided for percutaneous repair of an anatomical defect, such as an inguinal hernia. The method involves percutaneously accessing the inguinal canal of a patient. Following hernia reduction, if required, the hernia defect may be accessed and repaired percutaneously from within the inguinal canal. An implantable prosthesis may be percutaneously delivered into the inguinal canal. The prosthesis may be advanced along the inguinal canal from the percutaneous entry location to the defect site, where it may be deployed over and/or within the defect. A biocompatible foam material may be percutaneously delivered into the inguinal canal to reduce and/or repair the hernia defect. The foam may fill and solidify in the canal to prevent abdominal viscera from reentering the canal. Ablative therapy may be performed within the inguinal canal to cause a fibrotic response resulting in scar tissue formation and/or tissue shrinkage that narrows the canal.
    Type: Grant
    Filed: November 1, 2016
    Date of Patent: April 14, 2020
    Inventor: David Keane
  • Publication number: 20190021860
    Abstract: An implantable intracardiac device to prevent systolic anterior motion of the anterior mitral valve leaflet into the left ventricular outflow tract is described. The device comprises a blocking member configured for implantation within the left ventricle of the heart and in-situ blocking of systolic anterior motion of the mitral valve into the left ventricular outflow tract when anchored into the left ventricle of the heart. The device may be configured for radial expansion from a contracted orientation suitable for transluminal delivery to the left ventricle of the heart within a suitable delivery vehicle and an expanded orientation suitable for deployment within the left ventricle of the heart. The device comprises anchors configured for anchoring the device in-situ within the left ventricle to a wall of the left ventricle.
    Type: Application
    Filed: June 18, 2018
    Publication date: January 24, 2019
    Applicant: PARADOX MEDICAL LIMITED
    Inventor: David KEANE
  • Patent number: 10080660
    Abstract: An implantable intracardiac device to prevent systolic anterior motion of the anterior mitral valve leaflet into the left ventricular outflow tract is described. The device comprises a blocking member configured for implantation within the left ventricle of the heart and in-situ blocking of systolic anterior motion of the mitral valve into the left ventricular outflow tract when anchored into the left ventricle of the heart. The device may be configured for radial expansion from a contracted orientation suitable for transluminal delivery to the left ventricle of the heart within a suitable delivery vehicle and an expanded orientation suitable for deployment within the left ventricle of the heart. The device comprises anchors configured for anchoring the device in-situ within the left ventricle to a wall of the left ventricle.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: September 25, 2018
    Assignee: Paradox Medical Limited
    Inventor: David Keane
  • Publication number: 20180014786
    Abstract: A catheter for mapping the heart simultaneously accommodates a plurality of intravascular devices each having multiple electrode pairs carried on an exterior portion thereof. Each of the of intravascular devices is advancable and retractable relative to the distal end of the tubular catheter body independent of other vascular devices.
    Type: Application
    Filed: July 17, 2017
    Publication date: January 18, 2018
    Inventor: David Keane
  • Publication number: 20170332918
    Abstract: A Percutaneous Coronary Intervention (PCI) guidewire and method of use includes at least two pairs of small surface area, closely spaced electrodes spaced axially along the length of the guidewire to allow one electrode pair to be positioned on each side of a coronary stenosis. The electrodes can sense electrical signals from the myocardium immediately adjacent to the electrodes, enabling the guidewire to record and analyze an Intra-Coronary Electrogram (ICEG) and heart pacing, and, therefore, facilitate more accurately diagnosis of an individual patient's stenosis and provide a more patient specific diagnosis of clinical need.
    Type: Application
    Filed: May 17, 2017
    Publication date: November 23, 2017
    Inventor: David Keane
  • Publication number: 20170042656
    Abstract: A method and prosthesis is provided for percutaneous repair of an anatomical defect, such as an inguinal hernia. The method involves percutaneously accessing the inguinal canal of a patient. Following hernia reduction, if required, the hernia defect may be accessed and repaired percutaneously from within the inguinal canal. An implantable prosthesis may be percutaneously delivered into the inguinal canal. The prosthesis may be advanced along the inguinal canal from the percutaneous entry location to the defect site, where it may be deployed over and/or within the defect. A biocompatible foam material may be percutaneously delivered into the inguinal canal to reduce and/or repair the hernia defect. The foam may fill and solidify to in the canal to prevent abdominal viscera from reentering the canal. Ablative therapy may be performed within the inguinal canal to cause a fibrotic response resulting in scar tissue formation and/or tissue shrinkage that narrows the canal.
    Type: Application
    Filed: November 1, 2016
    Publication date: February 16, 2017
    Inventor: David Keane
  • Patent number: 9510926
    Abstract: A method and prosthesis is provided for percutaneous repair of an anatomical defect, such as an inguinal hernia. The method involves percutaneously accessing the inguinal canal of a patient. Following hernia reduction, if required, the hernia defect may be accessed and repaired percutaneously from within the inguinal canal. An implantable prosthesis may be percutaneously delivered into the inguinal canal. The prosthesis may be advanced along the inguinal canal from the percutaneous entry location to the defect site, where it may be deployed over and/or within the defect. A biocompatible foam material may be percutaneously delivered into the inguinal canal to reduce and/or repair the hernia defect. The foam may fill and solidify in the canal to prevent abdominal viscera from reentering the canal. Ablative therapy may be performed within the inguinal canal to cause a fibrotic response resulting in scar tissue formation and/or tissue shrinkage that narrows the canal.
    Type: Grant
    Filed: April 11, 2012
    Date of Patent: December 6, 2016
    Inventor: David Keane
  • Publication number: 20160220371
    Abstract: An implantable intracardiac device to prevent systolic anterior motion of the anterior mitral valve leaflet into the left ventricular outflow tract is described. The device comprises a blocking member configured for implantation within the left ventricle of the heart and in-situ blocking of systolic anterior motion of the mitral valve into the left ventricular outflow tract when anchored into the left ventricle of the heart. The device may be configured for radial expansion from a contracted orientation suitable for transluminal delivery to the left ventricle of the heart within a suitable delivery vehicle and an expanded orientation suitable for deployment within the left ventricle of the heart. The device comprises anchors configured for anchoring the device in-situ within the left ventricle to a wall of the left ventricle.
    Type: Application
    Filed: December 21, 2015
    Publication date: August 4, 2016
    Applicant: PARADOX MEDICAL LIMITED
    Inventor: David KEANE
  • Publication number: 20140180436
    Abstract: A method and prosthesis is provided for percutaneous repair of an anatomical defect, such as an inguinal hernia. The method involves percutaneously accessing the inguinal canal of a patient. Following hernia reduction, if required, the hernia defect may be accessed and repaired percutaneously from within the inguinal canal. An implantable prosthesis may be percutaneously delivered into the inguinal canal. The prosthesis may be advanced along the inguinal canal from the percutaneous entry location to the defect site, where it may be deployed over and/or within the defect. A biocompatible foam material may be percutaneously delivered into the inguinal canal to reduce and/or repair the hernia defect. The foam may fill and solidify in the canal to prevent abdominal viscera from reentering the canal. Ablative therapy may be performed within the inguinal canal to cause a fibrotic response resulting in scar tissue formation and/or tissue shrinkage that narrows the canal.
    Type: Application
    Filed: April 11, 2012
    Publication date: June 26, 2014
    Inventor: David Keane
  • Patent number: 6960206
    Abstract: A cardiac ablation catheter includes a coil-like ablating element that is deployable from an elongate, flexible sheath. The ablating element, while in the deployed position, has a shape with at least one revolution oriented in a plane that is orthogonal to a longitudinal axis of the sheath. The catheter system is well-suited to ablate a circumferential region of tissue about a pulmonary vein or the posterior wall of the left atrium proximate the pulmonary vein os. The treated tissue region electrically isolates the atria from the pulmonary vein.
    Type: Grant
    Filed: June 16, 2003
    Date of Patent: November 1, 2005
    Assignee: The General Hospital Corporation
    Inventor: David Keane